Please enable JS

Delta Healthcare Consulting

With nearly 20 years of experience in clinical trials, Delta Healthcare Consulting has created a wide network of study nurses in Belgium and the Netherlands who perform home visits or on site services on demand and who can support essential study-related tasks.


All their study nurses work in accordance with the same high standards, both at the hospital and at the patient’s home.


Delta Healthcare Consulting specialises in offering clinical trial services at the patient’s home. As an expert in patient recruitment, Delta Healthcare ensures patient involvement until the end of each clinical trial.


Learn more: www.deltaclinical.be

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

What role does AI play in lung cancer screening?

December 13, 2025

Mind Health With 53,000 new cases diagnosed each year, lung cancer is the deadliest cancer in France, according to data from the National Cancer Institute. Three-quarters of cases are detected at an advanced stage, which reduces the chances of recovery. The importance of screening is therefore crucial. In this field, the combination of low-dose CT […]

READ MORE
telemedecine technologies news

Quality Isn’t Just a Checkbox — Can Better Workforce Skills Drive Lower Costs?

November 27, 2025

Med City News Healthcare quality isn’t improving at scale, despite advances in technology, because many systems treat it as another compliance task rather than a priority. Stephanie Mercado, CEO of the National Association for Healthcare Quality (NAHQ), argued that investing in workforce skills and standardizing roles can drive safer, higher-quality care while delivering measurable cost […]

READ MORE
telemedecine technologies news

Truth in Reporting Clinical Trial Efficacy: A Call for Action

November 27, 2025

Trial Site News Clinical trial reporting of treatment efficacy is the foundation of public trust in medicine. Yet pharmaceutical companies often report efficacy measured as a relative risk reduction (RRR) while omitting the more relevant absolute risk reduction (ARR). This statistical sleight of hand can make clinically insignificant benefits look spectacular! Consider a simple example A risk is […]

READ MORE